Lupin Ltd.

₹2082.2

Lupin Ltd.

Add Alert
Add Watchlist

₹2082.2

₹2082.2

10.8 (0.52%) - 29 Nov 2025 04:25 PM

About Company

Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in many markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. 

Market Cap. ₹ 88,614 Cr.
52 Week - High/Low ₹ 2,403/1,795
P/E Ratio 17.00
P/B Ratio 3.65
Enterprise Value ₹ 89,032 Cr.
ROE % 17.78
RSI Value 46.99
EMA 50 1958.18
EMA 200 1971.49
Market Cap. ₹ 88,614 Cr.
52 Week - High/Low ₹ 2,403/1,795
P/E Ratio 23.94
P/B Ratio 5.15
Enterprise Value ₹ 87,884 Cr.
ROE % 21.13
RSI Value 46.99
EMA 50 1958.18
EMA 200 1971.49

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.